Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Raymond James Maintains Strong Buy on ICU Medical, Lowers Price Target to $180

Author: Benzinga Newsdesk | August 08, 2025 11:02am
Raymond James analyst Jayson Bedford maintains ICU Medical (NASDAQ:ICUI) with a Strong Buy and lowers the price target from $187 to $180.

Posted In: ICUI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist